Molecular epidemiological analysis of Mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South Africa.
Jolein G E LaumenLieke B van AlphenLiteboho D MadunaCharlotte M HoffmanJeffrey D KlausnerAndrew Medina-MarinoMarleen M KockRemco P H PetersPublished in: Sexually transmitted infections (2020)
This is the first study that determines resistance in M. genitalium infection since introduction of azithromycin in the syndromic management regimen for STIs in South Africa in 2015. Despite a well-established epidemic, azithromycin-resistant M. genitalium infection is still uncommon in the public healthcare sector. However, it has the potential to undermine the effectiveness of syndromic management. Introduction of molecular diagnostics and continuous surveillance are warranted for early detection emergence of resistance.